INSUBCONTINENT EXCLUSIVE:
declaration aims to ensure an adequate supply of pharmaceutical products, enhance disease surveillance and research efforts, and improve
patient care within healthcare services.The official decree, published in the Official Gazette El Peruano, also emphasizes the need to
strengthen the control of GBS cases, develop educational materials for public and healthcare personnel, and focus on prevention,
isolated in the context of mRna vaccination (Covid) as one of the main side effects, along with myocarditis.It manifests through symptoms
such as weakness and tingling in the feet and legs, which can progress to affect the upper body and, in severe cases, lead to
paralysis.According to the National Center for Epidemiology, Disease Prevention and Control, as of June 23, 2023, there have been 103
reported cases of the syndrome this year.The average monthly number of cases nationwide remains below 20, which is lower than the figures
observed in previous years, particularly during the 2019 outbreak.However, an uptick in cases has been observed since the end of June, with
16 reported cases compared to the earlier average range of 2 to 8 cases per week.Recognizing the potential impact on the availability of
